These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Kruithof EK, Gudinchet A, Bachmann F. Thromb Haemost; 1988 Feb 25; 59(1):7-12. PubMed ID: 3129809 [Abstract] [Full Text] [Related]
12. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. Lockwood CJ, Krikun G, Papp C, Aigner S, Schatz F. J Clin Endocrinol Metab; 1995 Apr 25; 80(4):1100-5. PubMed ID: 7714076 [Abstract] [Full Text] [Related]
13. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy. Booth NA, Reith A, Bennett B. Thromb Haemost; 1988 Feb 25; 59(1):77-9. PubMed ID: 3129811 [Abstract] [Full Text] [Related]
14. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. Genton C, Kruithof EK, Schleuning WD. J Cell Biol; 1987 Mar 25; 104(3):705-12. PubMed ID: 3102504 [Abstract] [Full Text] [Related]
15. Differential regulation of tissue factor and plasminogen activator inhibitor by human mononuclear cells. Schwartz BS, Bradshaw JD. Blood; 1989 Oct 25; 74(5):1644-50. PubMed ID: 2790190 [Abstract] [Full Text] [Related]
16. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Cubellis MV, Andreasen P, Ragno P, Mayer M, Danø K, Blasi F. Proc Natl Acad Sci U S A; 1989 Jul 25; 86(13):4828-32. PubMed ID: 2544876 [Abstract] [Full Text] [Related]